ADM has opened a new research and development (R&D) center focused on advancing research into animal microbiomes and developing tailored products within the health and wellness industry for pets, livestock and aquaculture.
In the 1,600-square-meter facility, located at the Biopôle life science campus on the north side of Lausanne, Switzerland, ADM’s scientists will undertake innovative pre-clinical research to tackle health challenges using biotics and other fermentation-derived ingredients that support the health and well-being of pets and farm animals.
"We are seeing significant growth in the global pet and farm animal microbiome market, as farmers and pet owners alike seek science-backed nutrition solutions to support the health and well-being of their pets and livestock. We are proud to launch this state-of-the-art research and development center, uniquely dedicated to microbiome research for pet and farm animal health and well-being, with the flexibility to adapt to emerging research demands," said Nuria Miquel, senior vice president and chief science officer at ADM. "The center will deploy cutting-edge scientific and technological tools to increase our understanding of the role of the gut microbiome in broader pet and animal health, building on our existing work in both human and animal nutrition, and support our development of science-backed microbiome solutions to bring to market for our customers. It represents a significant step forward in our purpose to advance animal wellness through science and innovation."
The global biotics in animal feed market had an estimated value of USD 5.2 billion in 2024 (Biotics for Livestock 2024-34). The gut microbiome has been linked to immune, digestive and absorptive functions, thereby affecting animal protein production and resource usage across species. Producers looking to optimize efficiency in performance and profitability are increasingly incorporating functional feed additives into animal diets.
